<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.malariajournal.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Malaria Journal - Latest Articles</title>
        <link>http://www.malariajournal.com</link>
        <description>The latest research articles published by Malaria Journal</description>
        <dc:date>2013-05-21T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/167" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/166" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/165" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/164" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/163" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/162" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/161" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/160" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/159" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/12/1/158" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.malariajournal.com/content/12/1/167">
        <title>Routine parallel diagnosis of malaria using microscopy and the malaria rapid diagnostic test SD 05FK60: the experience of Medecins Sans Frontieres in Myanmar</title>
        <description>Background:
Malaria rapid diagnostic tests (RDTs) are commonly used in Medecins Sans Frontieres (MSF) programmes to detect acute malaria infection. Programmes in regions with both Plasmodium falciparum and non-falciparum malaria (i.e. Plasmodium ovale, Plasmodium malariae and Plasmodium vivax) use a three-band P. falciparum/Pan test such as the SD Bioline Malaria Ag P.f/Pan 05FK60 (Standard Diagnostics, Kyonggi, Republic of Korea), hereafter referred to as SD 05FK60, as used by the MSF-Holland clinics in Rakhine state, Myanmar. In spite of published reports of generally good test performance, medical and paramedical staff on the ground often doubt the diagnostic accuracy of these RDTs.
Methods:
Parallel testing with malaria microscopy and RDT was conducted at two clinics in Rakhine state, Myanmar, for a period of 14 months as a programmatic response due to doubts and concerns of medical and paramedical staff into malaria RDTs.
Results:
A total of 2,585 blood samples from non-pregnant suspected malaria patients were examined by the SD 05FK60 RDT and microscopy at two clinics in Myanmar from October 2010 to December 2011. The reference standard microscopy diagnosed 531 P. falciparum and 587 P. vivax or P. malariae mono-infections. The overall sensitivity for P. falciparum detection by the SD 05FK60 was 90.2% (95% CI: 87.4-92.6) and for P. vivax/P. malariae 79.4% (95% CI: 75.9-82.6). The overall specificity for P. falciparum detection by the SD 05FK60 was 98.5% (95% CI: 97.7-99.1) and for P. vivax/P. malariae 98.7% (95% CI: 97.9-99.2). The sensitivity for P. falciparum was &gt;91% for parasitaemia levels of &gt;100-1,000 parasites/mul and increased for P. vivax/P. malariae with the parasitaemia level but was overall lower than for P. falciparum.25/408 and 13/420 cases, respectively, of P. falciparum and non-falciparum malaria were missed by the RDT.
Conclusion:
In field conditions in Myanmar, the SD 05FK60 malaria RDT performed consistent with other reports. The test detected malaria caused by P. vivax/P. malariae to a lesser extent than P. falciparum infection. Sensitivity improved with increasing parasitaemia level, however even at higher levels some infections were missed. The SD 05FK60 is adequate for use in settings where high quality microscopy is not available.</description>
        <link>http://www.malariajournal.com/content/12/1/167</link>
                <dc:creator>Cara Kosack</dc:creator>
                <dc:creator>Wint Thu Naing</dc:creator>
                <dc:creator>Erwan Piriou</dc:creator>
                <dc:creator>Leslie Shanks</dc:creator>
                <dc:source>Malaria Journal 2013, null:167</dc:source>
        <dc:date>2013-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-167</dc:identifier>
                                    <dc:description>In field conditions in Myanmar, the malaria RDT described performed consistent with other reports. The test detected malaria caused by P. vivax/P. malariae to a lesser extent than P. falciparum infection.</dc:description>
                <prism:require>/content/figures/1475-2875-12-167-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>167</prism:startingPage>
        <prism:publicationDate>2013-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/166">
        <title>Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean isolates</title>
        <description>Background:
Assaying for the parasitic lactate dehydrogenase (pLDH) is widely used as a rapid diagnostic test (RDT), but the efficacy of its serological effectiveness in diagnosis, that is antibody detection ability, is not known. The genetic variation of Korean isolates was analysed, and recombinant protein pLDH was evaluated as a serodiagnostic antigen for the detection of Plasmodium vivax malaria.
Methods:
Genomic DNA was purified, and the pLDH gene of P. vivax was amplified from blood samples from 20 patients. The samples came from five epidemic areas: Bucheon-si, Gimpo-si, and Paju-si of Gyeonggi Province, Gangwha-gun of Incheon metropolitan city, and Cheorwon-gun of Gangwon Province, South Korea, from 2010 to 2011. The antigenicity of the recombinant protein pLDH was tested by western blot and enzyme-linked immunosorbent assay (ELISA).
Results:
Sequence analysis of 20 Korean isolates of P. vivax showed that the open reading frame (ORF) of 951 nucleotides encoded a deduced protein of 316 amino acids (aa). This ORF showed 100% identity with the P. vivax Belem strain (DQ060151) and P. vivax Hainan strain (FJ527750), 89.6% homology with Plasmodium falciparum FCC1_HN (DQ825436), 90.2% homology with Plasmodium berghei (AY437808), 96.8% homology with Plasmodium knowlesi (JF958130), and 90.2% homology with Plasmodium reichenowi (AB122147). A single-nucleotide polymorphism (SNP) at nucleotide 456 (T to C) was also observed in the isolate from Bucheon, but it did not change in the amino acid sequence. The expressed recombinant protein had a molecular weight of approximately 32 kDa, as analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Of the 40 P. vivax patients, 34 (85.0%) were positive by ELISA.
Conclusions:
The pLDH genes of 19 isolates of P. vivax were identical, except one for SNP at nucleotide 456. This observation indicates that this gene is relatively stable. Based on these results, the relationship between antibody production against pLDH and the pattern of disease onset should be investigated further before using pLDH for serodiagnosis.</description>
        <link>http://www.malariajournal.com/content/12/1/166</link>
                <dc:creator>Hyun-Il Shin</dc:creator>
                <dc:creator>Jung-Yeon Kim</dc:creator>
                <dc:creator>Won-Ja Lee</dc:creator>
                <dc:creator>Youngjoo Sohn</dc:creator>
                <dc:creator>Sang-Wook Lee</dc:creator>
                <dc:creator>Yoon-Joong Kang</dc:creator>
                <dc:creator>Hyeong-Woo Lee</dc:creator>
                <dc:source>Malaria Journal 2013, null:166</dc:source>
        <dc:date>2013-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-166</dc:identifier>
                                    <dc:description>Parasite lactate dehydrogenase (pLDH) is widely used in rapid diagnostic tests:  the genetic variation of Korean isolates was analysed. The fact that the pLDH genes of 19 isolates of P. vivax were identical, except for one for SNP at nucleotide 456 indicates that this gene is relatively stable.</dc:description>
                <prism:require>/content/figures/1475-2875-12-166-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>166</prism:startingPage>
        <prism:publicationDate>2013-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/165">
        <title>Characterizing PvARP, a novel Plasmodium vivax antigen</title>
        <description>Background:
Plasmodium vivax continues to be the most widely distributed malarial parasite species in tropical and sub-tropical areas, causing high morbidity indices around the world. Better understanding of the proteins used by the parasite during the invasion of red blood cells is required to obtain an effective vaccine against this disease. This study describes characterizing the P. vivax asparagine-rich protein (PvARP) and examines its antigenicity in natural infection.
Methods:
The target gene in the study was selected according to a previous in silico analysis using profile hidden Markov models which identified P. vivax proteins that play a possible role in invasion. Transcription of the arp gene in the P. vivax VCG-1 strain was here evaluated by RT-PCR. Specific human antibodies against PvARP were used to confirm protein expression by Western blot as well as its subcellular localization by immunofluorescence. Recognition of recombinant PvARP by sera from P. vivax-infected individuals was evaluated by ELISA.
Results:
VCG-1 strain PvARP is a 281-residue-long molecule, which is encoded by a single exon and has an N-terminal secretion signal, as well as a tandem repeat region. This protein is expressed in mature schizonts and is located on the surface of merozoites, having an apparent accumulation towards their apical pole. Sera from P. vivax-infected patients recognized the recombinant, thereby suggesting that this protein is targeted by the immune response during infection.
Conclusions:
This study showed the characterization of PvARP and its antigenicity. Further assays orientated towards evaluating this antigen&apos;s functional importance during parasite invasion are being carried out.</description>
        <link>http://www.malariajournal.com/content/12/1/165</link>
                <dc:creator>Darwin Moreno-Pérez</dc:creator>
                <dc:creator>Ambar Saldarriaga</dc:creator>
                <dc:creator>Manuel Patarroyo</dc:creator>
                <dc:source>Malaria Journal 2013, null:165</dc:source>
        <dc:date>2013-05-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-165</dc:identifier>
                                    <dc:description>Characterization of the P. vivax asparagine-rich protein (PvARP) by a straightforward approach using molecular biology and immunochemistry assays. The reactivity with sera from individuals infected with P. vivax indicates that it contains epitopes that are target of antibody response generated during natural exposure.</dc:description>
                <prism:require>/content/figures/1475-2875-12-165-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>165</prism:startingPage>
        <prism:publicationDate>2013-05-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/164">
        <title>A potential threat to malaria elimination: extensive deltamethrin and DDT resistance to Anopheles sinensis from the malaria-endemic areas in China</title>
        <description>Background:
Insecticide resistance in malaria vectors is a growing concern in many countries and requires immediate attention because of the limited chemical arsenal available for vector control. There is lack of systematic and standard monitoring data of malaria vector resistance in the endemic areas, which is essential for the ambitious goal of malaria elimination programme of China.
Methods:
In 2010, eight provinces from different malaria endemic region were selected for study areas. Bioassays were performed on F1 progeny of Anopheles sinensis reared from wild-caught females using the standard WHO susceptibility test with diagnostic concentrations of 0.25% deltamethrin and 4% DDT.
Results:
For An. sinensis, the results indicated that exposure to 0.25% deltamethrin of F1 families with mortalities ranging from 5.96% to 64.54% and less than 80% mortality to DDT at the diagnostic concentration of 4% across the study areas.
Conclusions:
Anopheles sinensis was completely resistant to both deltamethrin and DDT, and resistance to pyrethroid has risen strikingly compared to that recorded during 1990s. The results highlight the importance of longitudinal insecticide resistance monitoring and the urgent need for a better understanding of the status of insecticide resistance in this region.</description>
        <link>http://www.malariajournal.com/content/12/1/164</link>
                <dc:creator>Duo-quan Wang</dc:creator>
                <dc:creator>Zhi-gui Xia</dc:creator>
                <dc:creator>Shui-sen Zhou</dc:creator>
                <dc:creator>Xiao-nong Zhou</dc:creator>
                <dc:creator>Ru-bo Wang</dc:creator>
                <dc:creator>Qing-feng Zhang</dc:creator>
                <dc:source>Malaria Journal 2013, null:164</dc:source>
        <dc:date>2013-05-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-164</dc:identifier>
                                    <dc:description>A paper that highlights the problem of insecticide resistance in malaria vectors in China.</dc:description>
                <prism:require>/content/figures/1475-2875-12-164-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>164</prism:startingPage>
        <prism:publicationDate>2013-05-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/163">
        <title>Fulani show decreased susceptibility to Plasmodium falciparum infection versus Mossi: data from a community-wide screening and treatment of asymptomatic carriers in Burkina Faso</title>
        <description>Background:
The Fulani ethnic group is known to have a lower susceptibility to Plasmodium falciparum infection than the Mossi.
Methods:
This commentary describes data from a recent cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of P. falciparum in 18 villages in Sapone, Burkina Faso.
Results:
The Fulani groups had a lower proportion of asymptomatic carriers at any occasion, a lower density of asexual forms and gametocytes of P. falciparum at baseline, and, in children under five years of age, lower rates of symptomatic malaria episodes per person-year than the Mossi.Discussion and conclusion: These data confirm previously reported differences in P. falciparum susceptibility between Fulani and Mossi.</description>
        <link>http://www.malariajournal.com/content/12/1/163</link>
                <dc:creator>Alfred Tiono</dc:creator>
                <dc:creator>Sodiomon Sirima</dc:creator>
                <dc:creator>Kamal Hamed</dc:creator>
                <dc:source>Malaria Journal 2013, null:163</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-163</dc:identifier>
                                    <dc:description>This study confirmed that, in the same environment, individuals belonging to the Fulani ethnic group have a lower susceptibility to Plasmodium falciparum infection than Mossi individuals.</dc:description>
                <prism:require>/content/figures/1475-2875-12-163-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>163</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/162">
        <title>Evaluation of the 2011 long-lasting, insecticide-treated net distribution for universal coverage in Togo</title>
        <description>Background:
Malaria remains a substantial public health problem in Togo. An integrated child health campaign was conducted in Togo in October 2011. This campaign included a component of free distribution of 2,799,800 long-lasting, insecticide-treated nets (LLINs) to households throughout Togo. This distribution marked the first effort in Togo at universal LLIN coverage and was not targeted specifically to children under five years and pregnant women, but to all household members. This study reports the results of the LLIN distribution campaign in terms of bed net possession and utilization.
Methods:
A representative household survey was implemented during the rainy season nine months after the LLIN distribution component of the campaign. Some 6,015 households selected through two stages of probability proportion to size stratified random sampling were interviewed using a brief questionnaire that included a demographic section with questions on the number of household members and sleeping spaces, and a campaign participation section with questions used to evaluate non-LLIN aspects of the campaign. A net roster listed all nets and their characteristics, and a household roster listed all members and visitors with information about bed net use. The questions addressed different aspects of bed net and LLIN possession and utilization. Crude weighted frequencies, percentages, and t- tests of association were calculated using the Stata 12.0 Survey features.
Results:
Possession of at least one bed net and/or LLIN increased from 41.3% to 96.7% (P &lt;0.001). Household possession of at least one campaign LLIN was 93.3%. Report LLIN among pregnant women was 77.5% and 79.3% for children under five. For the general population LLIN use was 68.3%.
Conclusions:
Due to the gap in LLIN possession and use and the significant number of individuals reporting a lack of nets as a reason for non-use, additional national LLIN distribution campaigns with a stronger educational component need to be implemented in order increase the use of available LLINs and to reach and maintain universal coverage of LLINs in Togo. The LLIN distribution campaign focusing on universal coverage of the general population in Togo was more successful at increasing LLIN possession and use of children under five years and pregnant women than other campaigns focusing only on these target groups.</description>
        <link>http://www.malariajournal.com/content/12/1/162</link>
                <dc:creator>Elizabeth Stevens</dc:creator>
                <dc:creator>Abigail Aldridge</dc:creator>
                <dc:creator>Yawo Degbey</dc:creator>
                <dc:creator>Akou Pignandi</dc:creator>
                <dc:creator>Monique Dorkenoo</dc:creator>
                <dc:creator>Justin Hugelen-Padin</dc:creator>
                <dc:source>Malaria Journal 2013, null:162</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-162</dc:identifier>
                                    <dc:description>Description of a largely successful campaign to distribute LLINs to all age-groups across Togo. The authors conclude that even though the campaign was unable to achieve the universal coverage target, it rapidly increased overall coverage and was far better than previous campaigns that targeted only pregnant women and under fives.</dc:description>
                <prism:require>/content/figures/1475-2875-12-162-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>162</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/161">
        <title>Providing open access data online to advance malaria research and control</title>
        <description>Background:
To advance research on malaria, the outputs from existing studies and the data that fed into them need to be made freely available. This will ensure new studies can build on the work that has gone before. These data and results also need to be made available to groups who are developing public health policies based on up-to-date evidence. The Malaria Atlas Project (MAP) has collated and geopositioned over 50,000 parasite prevalence and vector occurrence survey records contributed by over 3,000 sources including research groups, government agencies and non-governmental organizations worldwide. This paper describes the results of a project set up to release data gathered, used and generated by MAP.
Methods:
Requests for permission to release data online were sent to 236 groups who had contributed unpublished prevalence (parasite rate) surveys. An online explorer tool was developed so that users can visualize the spatial distribution of the vector and parasite survey data before downloading it. In addition, a consultation group was convened to provide advice on the mode and format of release for data generated by MAP&apos;s modelling work. New software was developed to produce a suite of publication-quality map images for download from the internet for use in external publications.
Conclusion:
More than 40,000 survey records can now be visualized on a set of dynamic maps and downloaded from the MAP website on a free and unrestricted basis. As new data are added and new permissions to release existing data come in, the volume of data available for download will increase. The modelled data output from MAP&apos;s own analyses are also available online in a range of formats, including image files and GIS surface data, for use in advocacy, education, further research and to help parameterize or validate other mathematical models.</description>
        <link>http://www.malariajournal.com/content/12/1/161</link>
                <dc:creator>Catherine Moyes</dc:creator>
                <dc:creator>William Temperley</dc:creator>
                <dc:creator>Andrew Henry</dc:creator>
                <dc:creator>Clara Burgert</dc:creator>
                <dc:creator>Simon Hay</dc:creator>
                <dc:source>Malaria Journal 2013, null:161</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-161</dc:identifier>
                                    <dc:description>A description of the construction of the Malaria Atlas Project&apos;s online data portal. It usefully details the data and associated products that the MAP team has made accessible to the global malaria community.</dc:description>
                <prism:require>/content/figures/1475-2875-12-161-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>161</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/160">
        <title>A member of the Plasmodium falciparum PHIST family binds to the erythrocyte cytoskeleton component band 4.1</title>
        <description>Background:
Plasmodium falciparum parasites export more than 400 proteins into the cytosol of their host erythrocytes. These exported proteins catalyse the formation of knobs on the erythrocyte plasma membrane and an overall increase in erythrocyte rigidity, presumably by modulating the endogenous erythrocyte cytoskeleton. In uninfected erythrocytes, Band 4.1 (4.1R) plays a key role in regulating erythrocyte shape by interacting with multiple proteins through the three lobes of its cloverleaf-shaped N-terminal domain. In P. falciparum-infected erythrocytes, the C-lobe of 4.1R interacts with the P. falciparum protein mature parasite-infected erythrocyte surface antigen (MESA), but it is not currently known whether other P. falciparum proteins bind to other lobes of the 4.1R N-terminal domain.
Methods:
In order to identify novel 4.1R interacting proteins, a yeast two-hybrid screen was performed with a fragment of 4.1R containing both the N- and &#945;-lobes. Positive interactions were confirmed and investigated using site-directed mutagenesis, and antibodies were raised against the interacting partner to characterise it&#8217;s expression and distribution in P. falciparum infected erythrocytes.
Results:
Yeast two-hybrid screening identified a positive interaction between the 4.1R N- and &#945;-lobes and PF3D7_0402000. PF3D7_0402000 is a member of a large family of exported proteins that share a domain of unknown function, the PHIST domain. Domain mapping and site-directed mutagenesis established that it is the PHIST domain of PF3D7_0402000 that interacts with 4.1R. Native PF3D7_0402000 is localized at the parasitophorous vacuole membrane (PVM), and colocalizes with a subpopulation of 4.1R.DiscussionThe function of the majority of P. falciparum exported proteins, including most members of the PHIST family, is unknown, and in only a handful of cases has a direct interaction between P. falciparum-exported proteins and components of the erythrocyte cytoskeleton been established. The interaction between 4.1R and PF3D7_0402000, and localization of PF3D7_0402000 with a sub-population of 4.1R at the PVM could indicate a role in modulating PVM structure. Further investigation into the mechanisms for 4.1R recruitment is needed.
Conclusion:
PF3D7_0402000 was identified as a new binding partner for the major erythrocyte cytoskeletal protein, 4.1R. This interaction is consistent with a growing body of literature that suggests the PHIST family members function by interacting directly with erythrocyte proteins.</description>
        <link>http://www.malariajournal.com/content/12/1/160</link>
                <dc:creator>Lindsay Parish</dc:creator>
                <dc:creator>Deborah Mai</dc:creator>
                <dc:creator>Matthew Jones</dc:creator>
                <dc:creator>Erika Kitson</dc:creator>
                <dc:creator>Julian Rayner</dc:creator>
                <dc:source>Malaria Journal 2013, null:160</dc:source>
        <dc:date>2013-05-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-160</dc:identifier>
                                    <dc:description>Identification of a novel interaction between the erythrocyte Band 4.1 protein and a P. falciparum component from the PHIST family of proteins. The paper should be of interest to groups working on the parasite &quot;exportome&quot;.</dc:description>
                <prism:require>/content/figures/1475-2875-12-160-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>160</prism:startingPage>
        <prism:publicationDate>2013-05-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/159">
        <title>Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests</title>
        <description>Background:
Early and accurate diagnosis of febrile patients is essential to treat uncomplicated malaria cases properly, prevent severe malaria, and avert unnecessary anti-malarial treatments. Improper use of anti-malarials increases the risk of adverse drug reaction and the evolution of drug/parasite resistance. While microscopy is the most common form of malaria diagnosis, concerns over its accuracy have prompted the incorporation of malaria rapid diagnostic tests (RDTs) into many national malaria control programmes.
Methods:
Over a three-month period, a direct comparison between microscopy and RDTs was made in a rural, private dispensary in the Kilombero Valley, Morogoro District, southern Tanzania, with the aim of estimating the extent of malaria over-diagnosis and over-treatment with anti-malarials. The study cohort was made up of patients referred by the dispensary&apos;s clinician for malaria testing. One hundred percent of patients approached agreed to participate in this study and were then tested using both microscopy and RDTs. Using the results from the comparison of the two tests at this dispensary, the potential cost effectiveness of introducing RDTs to a neighbouring public health centre was estimated on the basis of this centre&apos;s past malaria records spanning December 2007 to August 2011.
Results:
At the private dispensary, the apparent prevalence of malaria was 78% based on microscopy whereas the true prevalence, calculated using RDTs as the gold standard, was estimated at 14%. This discrepancy indicates that when using microscopy as the sole diagnostic test, malaria is being over-diagnosed by approximately a factor of five in this setting. At the public clinic, apparent malaria prevalence based on microscopy was 74%. If similar rates of over-diagnosis are assumed, 5,285 patients of the 6,769 patients positively diagnosed with malaria using microscopy were likely given unnecessary anti-malarials, and their true cause of illness was not addressed. The introduction of RDTs to the public clinic would be highly cost-efficient, with an estimated net saving of over 96 USD/month.
Conclusions:
Compared with RDTs, microscopy led to almost four out of five patients being over-diagnosed with malaria in this rural part of Tanzania. A policy that encompasses both the private and public sectors of health care is needed to ensure quality diagnostic testing for febrile patients. With estimated prevalence at 14%, RDT introduction is recommended given WHO findings that RDTs are predicted to be cost-effective in prevalence areas of less than 20%. The use of RDTs in malaria diagnosis would not only reduce government spending but would prove beneficial to ensuring appropriate care and treatment of febrile illness.</description>
        <link>http://www.malariajournal.com/content/12/1/159</link>
                <dc:creator>Kelly Harchut</dc:creator>
                <dc:creator>Claire Standley</dc:creator>
                <dc:creator>Andrew Dobson</dc:creator>
                <dc:creator>Belia Klaassen</dc:creator>
                <dc:creator>Clotilde Rambaud-Althaus</dc:creator>
                <dc:creator>Fabrice Althaus</dc:creator>
                <dc:creator>Katarzyna Nowak</dc:creator>
                <dc:source>Malaria Journal 2013, null:159</dc:source>
        <dc:date>2013-05-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-159</dc:identifier>
                                    <dc:description>Presumptive treatment used to be recommended by WHO, on the assumption that it is safer to treat non-malarial patients with anti-malarials than missing a true case of malaria. With a reduced incidence of malaria, a much increased cost of treatment and the realization of the risks of not identifying the true cause of febrile illness, there is now greater emphasis on accurate biological diagnosis. This study shows the advantages of using RDTs compared to poor quality microscopy.</dc:description>
                <prism:require>/content/figures/1475-2875-12-159-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>159</prism:startingPage>
        <prism:publicationDate>2013-05-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/12/1/158">
        <title>Physical condition of Olyset(R) nets after five years of utilization in rural western Kenya</title>
        <description>Background:
Long-lasting insecticidal nets (LLINs) are a cornerstone of malaria control at present, and millions are used each day across the globe. However, there is limited information about the durability of LLINs under different conditions of utilization and there is no consensus about when a LLIN ceases to be protective due to physical deterioration. This knowledge is important for malaria control programmes to plan for procurement and replacement.
Methods:
A cross-sectional survey of 208 households where Olyset(R) nets distributed five years ago were still present was conducted in the village of Sauri, western Kenya, in the context of the Millennium Villages Project. Information on bed net utilization and maintenance was collected in each household through a structured questionnaire, and one five-year old Olyset(R) net from each sampled household was randomly selected and collected for physical examination. All holes larger than 0.5 cm were measured in each net, registering their position, and a hole index was calculated following WHO guidelines. Nets were classified as in good condition, moderately damaged or badly torn based on the hole index. The analysis explored the associations between demographic and socioeconomic characteristics of households, patterns of bed net utilization and maintenance and physical condition of the nets. Additional analysis was conducted using malaria prevalence data collected in a separate survey to explore if there was any association between the condition of the net collected in a household and the presence of malaria parasites in members of that household.
Results:
81.4% of Olyset nets distributed five years ago were still present in the surveyed households, and 98.97% of the nets were reportedly used the previous night. Nets had an average of 34.2 holes (95% CI 30.12-38.22), and the mean hole index was 849 (95% CI 711-986), IQR 174-1,135. Only 15% of nets were still in good condition, 48% were moderately damaged and 37% were badly torn after five years of utilization. There was no association between household characteristics or patterns of bed net utilization or maintenance and physical condition of the nets. The only predictor of the physical condition of the net was the cleanliness at the time of examination. There was a difference of 17.6 per cent points in the proportion of households with at least one blood smear positive for Plasmodium falciparum between those with a net in good condition (5.3%) and those with a moderately damaged or badly torn net (22.9%), with a 95% CI (0.04-0.305), t=2.77 with unequal variance, 37.2 df, p=0.008.
Conclusions:
Olyset nets were used extensively in Sauri, western Kenya after five years of distribution, regardless of their physical condition. However, nets had a large number of holes, and only 15% were found in good condition. Nets in good condition seem to be still protective after five years of utilization, while nets with more than 100 cm2 of holed surface may be associated with higher malaria parasitaemia at household level. Continued replacement of damaged nets and promotion of net maintenance and repair may be necessary to maintain the protective effectiveness of LLINs.</description>
        <link>http://www.malariajournal.com/content/12/1/158</link>
                <dc:creator>Paola Mejia</dc:creator>
                <dc:creator>Hailay Teklehaimanot</dc:creator>
                <dc:creator>Yihenew Tesfaye</dc:creator>
                <dc:creator>Awash Teklehaimanot</dc:creator>
                <dc:source>Malaria Journal 2013, null:158</dc:source>
        <dc:date>2013-05-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-12-158</dc:identifier>
                                <prism:require>/content/figures/1475-2875-12-158-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>158</prism:startingPage>
        <prism:publicationDate>2013-05-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
